Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Expert Opin Investig Drugs. 2017 Apr 13;26(5):625–632. doi: 10.1080/13543784.2017.1312338
Drug Name Duvelisib
Phase I-III
Indication Hematological Malignancies
Pharmacology description PI3K δ/γ inhibitor
Route of administration Oral
Chemical Structure graphic file with name nihms895669t1.jpg
Pivotal Trial(s) Flinn I, et al [52]; O Brien, S et al [54]